FDA's Timeline for DTC Prescription Drug Ad Oversight

In September 2025, President Trump issued a statement pushing FDA to more strictly enforce existing regulations regarding DTC advertising for prescription drugs. At the time, the President’s memo argued that FDA was allowing too little information about the drugs to be included in the advertisements, leading in a rise in these sorts of ads.

HHS Secretary Kennedy has also highlighted his concerns with DTC prescription drug advertisements. At the time of the President’s statement, Secretary Kennedy issued a news release in which he said, ““Pharmaceutical ads hooked this country on prescription drugs. We will shut down that pipeline of deception and require drug companies to disclose all critical safety facts in their advertising. Only radical transparency will break the cycle of overmedicalization that drives America’s chronic disease epidemic.”

Since then, DTC advertisements have remained a talking point among the administration, but very little official action has been taken.

Dan Troy, currently a managing director and expert witness at Berkley Research Group and former lead counsel at FDA under previous administrations, spoke with Pharmaceutical Executive about the issues with regulating DTC advertisements. According to him, it might be harder to restrict these sorts of advertisements, which may not be having the negative impact officials have claimed.

Pharmaceutical Executive: What is the timeline for action to be taken by FDA?
Dan Troy: My sources tell me that the idea of a notice of proposed rulemaking on DTC ads to try and close the ostensible loophole (which is actually a recognition that the First Amendment will not allow a de facto ban on such truthful, not misleading, scientifically substantiated communications) is dead.

This administration, especially at FDA, they're not doing rulemaking. I think they recognize the average rulemaking at FDA has been taking from conception to notice of proposed rulemaking to comments to final getting all the way through the process about an average of eight years.

I was told by the recent outgoing head of the Office of Policy that there's just no rule making going on. They've tried to ramp up enforcement by sending out a bunch of letters, many of which I think have been rightly ignored. I don't think this administration is going to take any kind of significant action that's going to have any lasting effect on DTC ads.